Abstract
BackgroundLittle is known about the cost trajectory in patients starting biologics with moderate disease activity.ObjectivesTo compare 1-year health care costs and productivity losses after initiation of first biologic treatment in...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
